IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Mar 2005 (Vol: 2005, Issue: 57)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
Risk and Reward Published: 1 Mar-2005
By: Fintan Walton
Abstract Fulltext:
Section: Deal Trackers
Entereg (alvimopan) Published: 5 Mar-2005
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
Schering’s and Novartis’ New Co-Promotion Agreement for PTK/ZK Published: 5 Mar-2005
By: Business Review Editor
Abstract Fulltext:
Section: Features
Shire and New River: Buying up the Competition Published: 1 Mar-2005
By: Business Review Editor
Abstract Fulltext:
Sepracor and ACADIA Forge CNS Alliance Published: 1 Mar-2005
By: Business Review Editor
Abstract Fulltext:
Products under Development and the Licensing and Due Diligence Processes Published: 1 Mar-2005
By: Business Review Editor
Abstract Fulltext:
Technology Focus: Cell Therapy Published: 1 Mar-2005
By: Business Review Editor
Abstract Fulltext:
Section: General
Karo Bio AB Published: 5 Mar-2005
By: Business Review Editor
Abstract Fulltext:
Basilea’s Deal Making Debut Published: 5 Mar-2005
By: Business Review Editor
Abstract
Section: Licensing
Chiesi Licenses Second Drug to GB Therapeutics Published: 5 Mar-2005
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Valeant Expands Neurology Franchise through Acquisition of Xcel Published: 5 Mar-2005
By: Business Review Editor
Abstract Fulltext:
Antisoma Acquires Aptamera Published: 5 Mar-2005
By: Business Review Editor
Abstract Fulltext:
Giant Pfizer to Acquire Tiny Angiosyn Published: 5 Mar-2005
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Millennium and UCB Collaborate on Inflammation Published: 5 Mar-2005
By: Business Review Editor
Abstract Fulltext:

Login Problems

Please enter your username or email address and we will email you your login details.